medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2015, Number 3

<< Back Next >>

Arch Neurocien 2015; 20 (3)

Catatonia and delirium in neuropsychiatric patients: frequency, phenomenology and outcome

Pérez-González AF

Language: Spanish
References: 49
Page: 190-200
PDF size: 356.21 Kb.


ABSTRACT

Catatonia and delirium are two different syndromes. Catatonia is a psychomotor neuropsychiatric syndrome with a unique combination of behavioral and autonomic mental symptoms, motors, seen in psychiatric, neurological and medical conditions and after the administration of some drugs. Delirium is a syndrome neurocognitive usually abrupt onset, fluctuating course with prominent cognitive symptoms including impaired attention and consciousness. In this study, all patients with a diagnosis of catatonia and delirium assessment request for the service of neuropsychiatry treated in inpatient services at the National Institute of Neurology and Neurosurgery from 1 April to 30 September 2014. study prevalence, total interconsultations made from the date of baseline was taken as denominator. A total 270 patients, 96 of whom met criteria with the scales used to catatonia or delirium were evaluated. 86 They found 26 delirium and catatonia. 70% of patients had a subtype of catatonic excitement that is characterized by the presence of verbigeraciones, motor excitation, iterations, usage behavior and impulsivity. In this study of 70 patients with delirium was observed only according to the DSM 5 which 7 patients scored for stupor or absence of psychomotor activity, 5 patients scored for silence, 4 negativism and 15 agitation. It can be stated that there may be an overlap between both diagnostic as they can be shared between delirium symptoms hypoactive type and catatonia.


REFERENCES

  1. Fink M. Catatonia from its creation to DSM-V: Considerations for ICD. Indian J Psychiatry 2011;53(3):214-7.

  2. Association AP. DSM 5. Ame Psych Publishing 2013;969.

  3. Lawlor PG, Bush SH. Delirium diagnosis, screening and management. Curr Opin Support Palliat Care 2014;8(3):286-95.

  4. Ueda S, Takeuchi J, Okubo Y. Successful use of olanzapine for catatonia following delirium. Psych Clin Neurosci 2012; 66(5):465.

  5. Nunes ALS, Cheniaux E. Delirium and mania with catatonic features in a Brazilian patient: response to ECT. J Neuropsych Clin Neurosci 2014;26(1):E1-3.

  6. Upadhyaya SK, Pathania M, Sharma A. Multiple-etiology delirium and catatonia in an alcoholic with tubercular meningoencephalitis. Ind Psychiatry J 2011;20(2):139-41.

  7. Grover S, Ghosh A, Ghormode D. Do patients of delirium have catatonic features? An explorator y study. Psychiatry Clin Neurosci 2014;68(8):644-51.

  8. Delirium with catatonic features: a new subtype? | psychiatric times [Internet]. 2009 [citado 17 de noviembre de 2014]. Recuperado a partir de: http://www.psychiatrictimes.com/ ar ticles/delirium-catatonic-features-new-subtype

  9. Seethalakshmi R, Dhavale S, Suggu K, Dewan M. Catatonic syndrome: impor tance of detection and treatment with lorazepam. Ann Clin Psychiatry off J Am Acad Clin Psychiatr 2008;20(1):5-8.

  10. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51(9):357-62.

  11. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Act Psych Scand 1996;93(2):129-36.

  12. Peralta V, Cuesta MJ, Serrano JF, Mata I. The Kahlbaum syndrome: a study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder. Compr Psychiatry 1997;38(1):61-7.

  13. Ocampo Regla M, Ruiz López I, Sosa AL, Colin Piana R. Detección y frecuencia del síndrome catatónico en el Instituto Nacional de Neurología y Neurocirugía México. Arch Neurocienc Méx 2003;8(2):64-9.

  14. Bräunig P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry 1998;39(1):35-46.

  15. Starkstein SE, Petracca G, Tesón A, Chemerinski E, Merello M, Migliorelli R, et al. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 1996;60(3):326-32.

  16. Der G, Gupta S, Murray RM. Is schizophrenia disappearing? Lancet 1990;335(8688):513-6.

  17. Kendler KS, McGuire M, Gruenberg AM, Walsh D. Outcome and family study of the subtypes of schizophrenia in the west of Ireland. Am J Psychiatry 1994;151(6):849-56.

  18. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, et al. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary repor t on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 1986;16(4):909-28.

  19. Delirium in Critical Care. Anesthesia, intensive care, pain management [Internet]. Cambridge University Press. [17 de noviembre de 2014]. Recuperado a par tir de: http:// www.cambridge.org/us/academic/subjects/medicine/ anesthesia-intensive- care-pain-management/deliriumcritical- care

  20. Pisani MA, Kong SYJ, Kasl SV, Murphy TE, Araujo KLB, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009;180(11):1092-7.

  21. Neufeld KJ, Thomas C. Delirium: definition, epidemiology, and diagnosis. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 2013;30(5):438-42.

  22. Williams ST. Pathophysiology of encephalopathy and delirium. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 2013;30(5):435-7.

  23. Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001; 27(12): 1892-900.

  24. Fink M. Catatonia: a syndrome appears, disappears, and is rediscovered. Can J Psychiatry Rev Can Psychiatr 2009; 54(7):437-45.

  25. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 1987;22(8):1004-20.

  26. Munoz RA. Neuroleptic malignant syndrome and lethal catatonia. Am J Psychiatry 1987;144(10):1369-70.

  27. Singerman B, Raheja R. Malignant catatonia-a continuing reality. Ann Clin Psychiatry Off J Am Acad Clin Psychiatr 1994;6(4):259-66.

  28. Carof f SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41(3):79-83.

  29. Harsch HH. Neuroleptic malignant syndrome: physiological and laborator y findings in a series of nine cases. J Clin Psychiatry 1987;48(8):328-33.

  30. Meltzer HY, Cola PA, Parsa M. Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 1996;15(4):395-405.

  31. Northoff G, Wenke J, Pflug B. Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients. Psychol Med 1996;26(3):547-53.

  32. Rosebush PI, Mazurek MF. Serum iron and neuroleptic malignant syndrome. Lancet 1991;338(8760):149-51.

  33. Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 1998;44(6):499-507.

  34. Lee JW, Schwartz DL, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry Off J Am Acad Clin Psychiatr 2000;12(2):89-96.

  35. Mann SC, Carof f SN, Bleier HR, Welz WK, Kling MA, Hayashida M. Lethal catatonia. Am J Psychiatry 1986;143 (11):1374-81.

  36. Fricchione GL. Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry 1985;20(3):304-13.

  37. Kellam AM. The neuroleptic malignant syndrome, so-called. A survey of the world literature. Br J Psychiatry J Ment Sci 1987;150:752-9.

  38. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93(2):137-43.

  39. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77(1):185-202.

  40. Kostas TRM, Zimmerman KM, Rudolph JL. Improving delirium care: prevention, monitoring, and assessment. The Neurohospitalist 2013;3(4):194-202.

  41. Fink M, Taylor MA. Drs. Fink and Taylor Reply. Am J Psychiatry 2007;164(3):525.

  42. Guía de bolsillo de la clasificación CIE-10: clasificación de los trastornos mentales y del comportamiento. Ed. Médica Panamericana; 2000.

  43. Fink M, Taylor MA. Catatonia: a clinician’s guide to diagnosis and treatment. Cambridge University Press; 2006. 280.

  44. Bräunig P, Krüger S, Shugar G, Höf fler J, Börner I. The catatonia rating scale I-development, reliability, and use. Compr Psychiatry 2000;41(2):147-58.

  45. Krüger S, Bagby RM, Höffler J, Bräunig P. Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Compr Psychiatry 2003;44(6):472-82.

  46. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23(1):89-97.

  47. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986;143(1):35-9.

  48. Yudofsky SC, Kopecky HJ, Kunik M, Silver JM, Endicott J. The overt agitation severity scale for the objective rating of agitation. J Neuropsychiatry Clin Neurosci 1997;9(4):541-8.

  49. Ramírez-Bermúdez J, Aguilar-Venegas LC, Calero-Moscoso C, Ramírez-Abascal M, Nente-Chávez F, Flores-Reynoso S, et al. Neurology-psychiatry inter face in central nervous system diseases. Gac Méd Méx 2010;146(2):108-1.




2020     |     www.medigraphic.com